PipelinePharma Logo

Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Deferiprone manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

4 products found

deferiprone

Capsules 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #36197

Established in 2018, this manufacturer specializes in exporting and manufacturing pharmaceutical active pharmaceutical ingredients (APIs) and finished formulations, including tablets, capsules, pre-filled syringes, dry syrups, creams, ointments, injectables (liquids and powder), eye/ear drops, IV fluids, and surgical products. As a CTD dossier owner and manufacturer, it holds EU/WHO GMP certifications, ensuring compliance with international quality standards. The manufacturer operates advanced production lines adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across various regions, including Central America, non-EU Europe, the Middle East, Oceania, South America, and South Asia.

Manufacturer usually replies in nan days

deferiprone

Capsules 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Comments
CDP With Ferriprox,Apotex, Europe ROW & Semiregulated Market
Manufacturer #20862
This company is a quality-driven, customer-centric pharmaceutical manufacturer specializing in generic finished dosage formulations. A subsidiary of a multinational group headquartered in Southeast Asia, it boasts an annual turnover exceeding US$150 million and operates as both a contract manufacturer for global MNCs and a producer of its own branded medications. The company emphasizes affordability and accessibility, aiming to meet unmet patient needs. Their focus lies on developing products across multiple therapy areas, utilizing various dosage forms. They possess GMP certifications and hold patents for their products. While primarily based in South Asia, they aim to expand their reach into the EU and North America through strategic partnerships and collaborations.

Manufacturer usually replies in 14 days

deferiprone

Oral suspension 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20801
This pharmaceutical manufacturer specializes in producing a wide range of medications across various dosage forms, including tablets, capsules, injections, and syrups. Their focus is on delivering high-quality formulations for human health, evident in their commitment to using state-of-the-art technology and machinery. The company exports its products to several key regions globally, such as Africa, the CIS countries, Central and Latin America, Southeast Asia, and the Pacific. While they haven't specified particular therapy areas, their mission statement emphasizes a dedication to becoming a dominant player in both domestic and international markets. They prioritize maintaining the highest quality standards through rigorous quality control measures and emphasize safe, stable packaging for all products.

Manufacturer usually replies in 11 days

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Deferiprone is an iron chelator medication used to treat thalassemia major. Suppliers of deferiprone market it in the form of 500mg and 1000mg oral tablets. The developer and earliest manufacturer of deferiprone is Apotex Pharmaceuticals, which first introduced the drug into the market in 1994. It is currently approved in over 60 countries worldwide, including but not limited to China, Australia, the U.S., and across Europe. Apotex remains the largest manufacturer and supplier of deferiprone medications globally. Retail prices per 100 (500mg) tablets of deferiprone are typically around 300 EUR.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible